جست‌وجوی استاد و پژوهشگر

• Walking
• Gait Analysis
• Systematic Reviews
• +۵ مورد دیگر

Eva Swinnen is a researcher at the Vrije Universiteit Brussel within the Brubotics Rehabilitation Research Center, focusing on physiotherapy, human physiology, and anatomy. Her work bridges robotics and rehabilitation medicine. Key research areas: Walking (100%), Gait Analysis (86%), Systematic Reviews (59%), Orthotic Devices (51%) Recent Publications (2025): Explore AI applications in stroke rehabilitation, virtual twin technology, and electrotherapy effects on muscle recovery. Notable collaborations include projects with KU Leuven and Radboud University Medical Center. 2022 Kuka Innovation Award Finalist 2019 Phase I & II App Development Competition Winner Supervision: Guided master's theses on topics like Kinect™ system validation, volleyball spike biomechanics, and EMG patterning in motor tasks. Currently involved in EU-funded TARGET consortium initiatives for stroke management.

• Neuroscience
• Neuroimmunology
• Multiple Sclerosis (MS)
• +۴ مورد دیگر

Bénédicte Dubois is a full professor at the Faculty of Medicine, KU Leuven , leading the Experimental Neurology Research Group and the Laboratory for Neuroimmunology . She is also a member of the KU Leuven Brain Institute and KU Leuven Cancer Institute , focusing on neuroimmunology and multiple sclerosis (MS) research. Researcher - Experimental Neurology Research Group, KU Leuven Chair - Academic Consultants for Medicine, KU Leuven Research Interests : Her work spans neuroimmunology , multiple sclerosis , and neuroinflammation , with expertise in single-cell transcriptomics , microglial activation , and Epstein-Barr virus interactions in MS. Key projects include: Exploring exosomal miRNA and Epstein-Barr virus mechanisms in MS Decoding pathogenetic pathways in MS using multimodal single-cell analysis Investigating natural killer cell subsets in MS brain pathology Validating MRI-based brain atrophy measurements for MS patients Publications : Recent studies highlight her contributions to MS prognosis via biomarkers like CHIT1, optical coherence tomography as a predictive tool, and genetic mosaicism in immune cells. Her work is frequently presented at major conferences like the Joint ECTRIMS-ACTRIMS meeting. Academic Contributions : She supervises numerous PhD students, serves on institutional councils (including the Faculty Council of Medicine ), and leads multidisciplinary collaborations. Her research integrates clinical neurology , genomics , and immunology to advance MS understanding.

• Neurology
• Nuclear Medicine
• Neurodegenerative Diseases
• +۷ مورد دیگر

Aline Delva serves as a Clinical Lecturer at KU Leuven's Faculty of Medicine, where she is affiliated with the Parkinson's Research Laboratory. Her academic activities integrate clinical neurology with advanced nuclear medicine techniques, focusing on diagnostic differentiation of neurodegenerative disorders through biomarker discovery and neuroimaging validation. She contributes to undergraduate medical education through specialized neurology skills courses and advanced neurobiology modules. Dr. Delva's research centers on Parkinsonian syndromes, dementia with Lewy bodies, and Huntington's disease, with particular emphasis on cardiac noradrenergic imaging using [18F]-MFBG PET and [123I]-MIBG SPECT. Her work explores plasma biomarkers (pTau181, amyloid, astrocytic markers) for predicting dementia conversion in idiopathic REM sleep behavior disorder, investigates synaptic density changes in early neurodegeneration, and develops radioligands for mutant huntingtin imaging. She actively examines environmental risk factors like nicotine exposure in Parkinson's disease pathogenesis. Analysis of her 2023-2025 publications reveals consistent methodological focus on comparative neuroimaging validation and biomarker discovery across multiple neurodegenerative conditions. Key thematic clusters include cardiac sympathetic imaging for differential diagnosis of Parkinson's disease versus multiple system atrophy, plasma biomarker trajectories in prodromal dementia, and Huntington's disease imaging biomarker standardization. Her collaborative work spans international consortia including the European Huntington's Disease Network. No scientific awards are documented in the available information. Dr. Delva holds co-promoter roles in two major research projects: a prospective comparison of cardiac [18F]-MFBG PET versus [123I]-MIBG SPECT for differential diagnosis of Parkinson's disease and related disorders (2023-2027), and investigation of [18F]-MFBG PET for early differentiation in Parkinson's disease and dementia with Lewy bodies (2023-2027). While formal student listings are absent, her laboratory mentorship likely extends to junior researchers through the Parkinson's Research Laboratory and clinical teams. She operates within KU Leuven's Parkinson's Research Laboratory, collaborating with nuclear medicine specialists at University Hospitals Leuven and participating in the European Huntington's Disease Network Imaging Working Group. Her multidisciplinary team integrates neurologists, nuclear medicine physicians, and basic scientists to translate imaging findings into clinical diagnostic applications for neurodegenerative disorders.

• Neurodegenerative Diseases
• Parkinson's Disease
• Multiple System Atrophy
• +۵ مورد دیگر

Wouter Peelaerts serves as a Tenure Track Assistant Professor in the Department of Pharmaceutical and Pharmacological Sciences at KU Leuven's Faculty of Pharmaceutical Sciences. He holds cross-institute appointments at the ADVANTAGE research group (Advanced Disease Modelling, Targeted Drug Discovery and Gene Therapy), KU Leuven Brain Institute (LBI), Institute for Rare Diseases (Leuven.IRD), and Institute for Single Cell Omics (LISCO), while participating in faculty and departmental councils as senior academic staff. His research centers on neurodegenerative mechanisms in Parkinson's disease and multiple system atrophy (MSA), with emphasis on α-synuclein pathology propagation, oligodendrocyte dysfunction, and infection-triggered neurodegeneration. Key investigations explore how urinary tract infections initiate synucleinopathy via innate immune responses and how α-synuclein strain variations dictate disease phenotypes. His work integrates gene therapy approaches and small-molecule drug discovery targeting neuroinflammatory pathways. Analysis of his 2020-2024 publications reveals consistent focus on experimental models (iPSCs, organoids, rodent systems) to dissect α-synuclein transmission mechanisms. Dominant themes include strain-specific pathology in synucleinopathies, oligodendroglial contributions to MSA severity, and peripheral infection as a catalyst for central nervous system degeneration. Methodologically, his work bridges molecular neuropathology with translational immunology. Peelaerts leads or co-leads ten active research projects funded through 2027, including investigations into α-synuclein modulators for Parkinson's disease, oligodendrocyte roles in neurodegeneration models, and urinary tract infection-triggered synucleinopathy. His grant portfolio demonstrates sustained focus on infection-neurodegeneration links and oligodendroglial mechanisms across multiple system atrophy subtypes. Within the ADVANTAGE research group, he collaborates across KU Leuven's neuroscience ecosystem, leveraging resources from the Brain Institute, Rare Diseases Institute, and Single Cell Omics Institute to develop integrated models of proteinopathy and neuroinflammation. His team utilizes cutting-edge technologies including viral vector delivery systems and single-cell functional profiling for mechanistic studies.

Ivan Bautmansمشاهده پروفایل

پژوهشگر

• Gerontology
• Musculoskeletal Health
• Immunology
• +۳ مورد دیگر

Ivan Bautmans is a researcher at the Physical Medicine and Rehabilitation department of Vrije Universiteit Brussel. His roles include leadership positions such as Head of the Vitality Research Group and involvement in projects like the Gerontopole Brussels. He focuses on mechanisms and interventions for muscle weakness (dynapenia) and atrophy (sarcopenia) in aging populations, with particular attention to inflammatory processes. Research Interests : Gerontology and musculoskeletal health Exercise interventions for frailty prevention Immune system and inflammation in aging Technological solutions for elderly mobility (e.g., exoskeletons) Recent Trends in Publications : Prioritizes translational research linking exercise physiology to clinical outcomes, emphasizing cognitive benefits of resistance training and immune modulation. Explores gerontechnology applications for functional aging. Grants & Projects : STIMULATE (2025-2028): Investigates muscle-immune cell communication Gerontopole Brussels (2023-2028): Focuses on active & healthy aging Awards : Multiple awards from Belgian Gerontology Association (2001-2004) De Cooman Price and Price Borgerhoff (2010) Lab & Teams : Vitality Research Group, collaborating with institutions like UZB and international partners (e.g., Lithuania, Portugal).

• Nuclear Medicine
• Molecular Imaging
• Neurodegenerative Diseases
• +۹ مورد دیگر

Koenraad Van Laere is a full professor at the Department of Imaging & Pathology , Faculty of Medicine , KU Leuven . He serves as department chair and heads multiple divisions including Nuclear Medicine & Molecular Imaging , Division Molecular Imaging Research and Clinic Leuven , and several subdivisions under the Miracle research group. He is also a member of the KU Leuven Brain Institute and KU Leuven Cancer Institute . His research focuses on Nuclear Medicine & Molecular Imaging , with emphasis on neurodegenerative disorders such as Alzheimer's Disease , Parkinson's Disease , and Amyotrophic Lateral Sclerosis (ALS) . He develops novel PET tracers for early diagnosis, disease progression monitoring, and therapeutic target identification. The recent publications highlight his work on Tau PET imaging in cognitive disorders, HDAC6 tracers for ALS, and synaptic density loss in Alzheimer’s disease. His projects include ultrahigh-resolution PET applications in brain nuclei, spinal cord, and limbic structures, along with clinical trials comparing imaging modalities like PET/CT, MRI, and SPECT. Van Laere's affiliations include leadership roles in the Research Policy Council , Faculty of Medicine Council , and Department of Imaging & Pathology Board . He also contributes to educational programs in nuclear medicine and problem-solving skills.